Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Analysis of risk factors and construction of predictive model for deep vein thrombosis after core decompression in patients with osteonecrosis of the femoral head].

Zhonghua yi xue za zhi·2026
Same author

A sudden change and recovery in the magnetic environment around a repeating fast radio burst.

Science (New York, N.Y.)·2026
Same author

[A case of double-ventricular arrhythmogenic cardiomyopathy with mitral annular disjunction].

Zhonghua xin xue guan bing za zhi·2026
Same author

[Clinical characteristics and maternal and fetal outcomes of pregnancy complicated with chronic kidney disease stage 4-5].

Zhonghua fu chan ke za zhi·2025
Same author

[Expert consensus on the treatment of chronic rhinosinusitis with nasal polyps with biologics (2025)].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

[Genetic and clinical characteristics in epilepsy patients with ATP6V1A gene variants].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2025

Related Experiment Video

Updated: Jul 15, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

Particle deposition in obstructed airways.

H Y Luo1, Y Liu, X L Yang

  • 1Department of Mechanical Engineering, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.

Journal of Biomechanics
|May 15, 2007
PubMed
Summary

Airway obstruction in chronic obstructive pulmonary disease (COPD) significantly alters particle deposition in the lungs. Computational fluid dynamics show obstructed airways increase particle impaction and deposition efficiency downstream.

More Related Videos

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Experiment Videos

Last Updated: Jul 15, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Area of Science:

  • Pulmonary medicine
  • Biomedical engineering
  • Respiratory physiology

Background:

  • Chronic obstructive pulmonary disease (COPD) causes airway inflammation and obstruction, affecting respiratory function.
  • Understanding particle deposition in narrowed airways is crucial for managing lung diseases.
  • Bifurcation points in airways are critical sites for particle deposition.

Purpose of the Study:

  • To investigate the impact of airway obstruction on particle motion and deposition in human lung models.
  • To quantify changes in particle deposition efficiency due to simulated COPD-induced airway narrowing.

Main Methods:

  • Generation of four-generation, three-dimensional lung models based on Weibel's morphometry.
  • Utilizing computational fluid dynamics (CFD) to solve incompressible laminar Navier-Stokes equations.
  • Comparison of a healthy airway model with three models featuring obstruction at different generations.

Main Results:

  • Obstructed airways significantly influence particle deposition downstream of the obstruction.
  • Narrowed airways alter the velocity profiles at bifurcations.
  • Increased particle impaction on airway dividers leads to higher deposition efficiency in obstructed models.

Conclusions:

  • Airway obstruction, a hallmark of COPD, substantially increases particle deposition in the lungs.
  • CFD modeling provides valuable insights into the mechanisms of particle deposition in diseased airways.
  • These findings can inform strategies for targeted drug delivery and disease management in COPD patients.